Clinical trial
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients…
NCT00003389 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003389 |
|---|---|
| Title | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma |
| Official title | A Randomized Phase III Trial of ABVD Versus Stanford V (+/-) Radiation Therapy in Locally Extensive and Advanced Stage Hodgkin's Disease |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug, Radiation |
| Interventions | Doxorubicin, Bleomycin, Vinblastine, Dacarbazine, Vincristine, Mechlorethamine, Etoposide, Prednisone, Cyclophosphamide, Radiotherapy |
| Enrollment | 854 |
| Start date | Jun 17, 1999 |
| Primary completion | Sep 1, 2011 |
| Completion | May 1, 2016 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 29, 2023 |
| Countries | Canada, South Africa, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: